Related Experiment Videos
[Markers of prostatic carcinoma]
1Urologická klinika 1. LF UK a VFN Praha.
Casopis Lekaru Ceskych
|October 27, 1998
Summary
This review surveys current and emerging prostate carcinoma markers, detailing their origins, clinical utility, and diagnostic performance. It highlights the potential of novel molecular genetics-based markers for improved patient care.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Prostate carcinoma diagnosis and management rely on accurate biomarkers.
- Existing markers have limitations in sensitivity and specificity.
- Advancements in molecular genetics offer new avenues for biomarker discovery.
Purpose:
- To provide a comprehensive overview of established prostate carcinoma markers.
- To evaluate the clinical utility, sensitivity, and specificity of these markers.
- To explore the future potential of novel molecular genetics-derived biomarkers.
Summary:
- The author reviews known prostate carcinoma markers, including their origins and applications in research and clinical practice.
- Discussion encompasses the diagnostic accuracy (sensitivity and specificity) of current biomarkers.
- Emerging markers identified through molecular genetics are presented with their prospective clinical integration.
Impact:
- Enhances understanding of prostate carcinoma biomarker landscape.
- Informs clinical decision-making by detailing marker performance.
- Guides future research and development of more effective diagnostic tools for prostate cancer.